Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah P Psutka

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Cancer|June 10, 2020
Personalizing preoperative risk stratification and refining patient selection for cytoreductive nephrectomy in metastatic renal cell carcinomaSarah P Psutka
Annals of Surgical Oncology|January 9, 2022
Muscle Mass Matters in Patients with Renal Cell Carcinoma, but That Is Only the Beginning…Sarah P Psutka
Urologic Oncology|July 1, 2020
Introduction: Personalizing risk stratification in bladder cancer: Moving away from "the eyeball test" and embracing objective quantification of riskSarah P Psutka
European Urology Focus|February 16, 2024
Prehabilitation: A multidimensional adjunct to comprehensive personalized oncologic care. But, can we make it pragmatic?Sarah P Psutka
European Urology Focus|August 30, 2018
Unraveling Associations Between Occupation and Bladder Cancer Aggressiveness: Describing the LandscapeSarah P Psutka, Sima Porten
Journal of Pediatric Urology|June 5, 2012
Bladder diverticula in childrenSarah P Psutka, Marc Cendron
Urology|October 12, 2024
Editorial Comment on "Comparing Frailty Indices for Risk Stratifi cation in Urologic Oncology: Which Index to Choose?"Alex Zhu, Sarah P Psutka
European Urology|June 9, 2026
Safety, Hemostasis, and Surgical Precision: Reconsidering Tranexamic Acid in Contemporary Urologic SurgeryOlutiwa Akinsola, Sarah P Psutka
Urologic Oncology|February 11, 2020
Risk stratification metrics for bladder cancer: Comprehensive Geriatric AssessmentsAdam J Gadzinski, Sarah P Psutka
Annals of Surgical Oncology|June 19, 2023
Adding Stereotactic Radiation to the Multidisciplinary Armamentarium for Localized Renal Cell Carcinoma: Ready for Primetime? : An Editorial Regarding a Recent 5-Year Efficacy and Safety Report of a Multicenter Cohort of Primary RCC Patients Treated with SABRElizabeth L Koehne, Sarah P Psutka
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Cancer|June 10, 2020
Personalizing preoperative risk stratification and refining patient selection for cytoreductive nephrectomy in metastatic renal cell carcinomaSarah P Psutka
Annals of Surgical Oncology|January 9, 2022
Muscle Mass Matters in Patients with Renal Cell Carcinoma, but That Is Only the Beginning…Sarah P Psutka
Urologic Oncology|July 1, 2020
Introduction: Personalizing risk stratification in bladder cancer: Moving away from "the eyeball test" and embracing objective quantification of riskSarah P Psutka
European Urology Focus|February 16, 2024
Prehabilitation: A multidimensional adjunct to comprehensive personalized oncologic care. But, can we make it pragmatic?Sarah P Psutka
European Urology Focus|August 30, 2018
Unraveling Associations Between Occupation and Bladder Cancer Aggressiveness: Describing the LandscapeSarah P Psutka, Sima Porten
Journal of Pediatric Urology|June 5, 2012
Bladder diverticula in childrenSarah P Psutka, Marc Cendron
Urology|October 12, 2024
Editorial Comment on "Comparing Frailty Indices for Risk Stratifi cation in Urologic Oncology: Which Index to Choose?"Alex Zhu, Sarah P Psutka
European Urology|June 9, 2026
Safety, Hemostasis, and Surgical Precision: Reconsidering Tranexamic Acid in Contemporary Urologic SurgeryOlutiwa Akinsola, Sarah P Psutka
Urologic Oncology|February 11, 2020
Risk stratification metrics for bladder cancer: Comprehensive Geriatric AssessmentsAdam J Gadzinski, Sarah P Psutka
Annals of Surgical Oncology|June 19, 2023
Adding Stereotactic Radiation to the Multidisciplinary Armamentarium for Localized Renal Cell Carcinoma: Ready for Primetime? : An Editorial Regarding a Recent 5-Year Efficacy and Safety Report of a Multicenter Cohort of Primary RCC Patients Treated with SABRElizabeth L Koehne, Sarah P Psutka
Pageof 18